Asset type Foreign Equity Sector
The most effective way to invest in the fast-growing industry, Biotechnology. KODEX Synth-US bio mainly focuses on USA's biotechnology companies committed to healthier future.
Last data obtained Quotes delayed at least 20 minutes. Market data provided by KOSCOM.
Refers to the current value of future income generated from investments into bonds discounted at an appropriate discount rate.
25,910
Net Asset Value (NAV): Net Asset Amount refers to the assets of the ETF less the liabilities the ETF has to pay.
This total Net Asset Amount divided by the total number of securities in the ETF is called the Base Price or Net Asset Value (NAV).
In other words, NAV refers to the ETF per share value. It is announced once a day based on the closing market prices from the previous day.
Indicative NAV (iNAV): Value of the ETF calculated in real-time, reflecting the current price of the assets the ETF holds.
Investors make their trades with reference to this price. As such, ETF transaction prices usually form approximate to the iNAV.
Depending on the sentiment of market participants, however, the transaction price may be higher than the iNAV (overvaluation), or conversely lower than iNAV (undervaluation).
26,132
down 330 (-1.25%)
Trading Volume (shares)
7,481
* as of Apr 15, 2024
S&P Biotechnology Select Industry Index(KRW)
The S&P Biotechnology Select Sector Index seeks to track the Biotechnology sector - stock classifications are based on the Global Industry Classification Standard (GICS).
View index information in detail| Net Assets | 17 (billion) | Base Currency | KRW |
|---|---|---|---|
| Inception Date | October 31, 2013 | General Administrator |
Shinhan Aitas |
| Gross Expense Ratio |
0.250% (AP : 0.001%, Manager Fee : 0.209%, Trustee Fee : 0.020%, General Administrator Fee : 0.020%) |
Trustee | KB Bank |
| Dividend | No dividend distribution | Related Documents |
- |